A 62-year-old man with COPD GOLD stage III (FEV₁ 35% predicted) presents with acute exacerbation: increased dyspnea, purulent sputum, and fever for 3 days. On examination: RR 28/min, SpO₂ 88% on room air, accessory muscle use. Chest X-ray shows no infiltrate. ABG: pH 7.32, PaCO₂ 52 mmHg, HCO₃⁻ 26 mEq/L, PaO₂ 58 mmHg. What is the most appropriate immediate next step?

Explanation

## Clinical Context This patient has COPD exacerbation with hypoxemia (SpO₂ 88%), tachypnea (RR 28), and **respiratory acidosis** (pH 7.32, PaCO₂ 52 mmHg). The combination of hypoxemia + CO₂ retention + accessory muscle use signals impending ventilatory failure. ## Rationale for Correct Answer **Key Point:** Non-invasive ventilation (NIV) is the first-line intervention for acute exacerbation of COPD with acute respiratory acidosis (pH < 7.35, PaCO₂ > 45 mmHg) and hypoxemia, provided the patient is conscious, cooperative, and has no contraindications. **High-Yield:** NIV reduces intubation rate, mortality, and ICU stay duration in COPD exacerbation with acidosis. It should be initiated **before** oxygenation alone, which risks worsening CO₂ retention in COPD patients (loss of hypoxic drive). **Clinical Pearl:** In COPD, supplemental oxygen without ventilatory support can paradoxically increase PaCO₂ by removing hypoxic respiratory drive and increasing dead space ventilation. Always pair oxygen with ventilatory support when CO₂ is elevated. ## Management Algorithm ```mermaid flowchart TD A[COPD exacerbation + hypoxemia]:::outcome --> B{Respiratory acidosis?}:::decision B -->|Yes: pH < 7.35, PaCO₂ > 45| C[Assess NIV candidacy]:::decision B -->|No: normal pH/CO₂| D[Oxygen + medical therapy]:::action C -->|Conscious, cooperative, no contraindications| E[Initiate NIV + O₂ target 88-92%]:::action C -->|Contraindications or failed trial| F[Intubation]:::urgent E --> G[Monitor ABG in 1-2 hrs]:::action G -->|Improvement| H[Continue NIV, wean as tolerated]:::action G -->|Deterioration| F ``` ## Oxygen Target in COPD | SpO₂ Target | Rationale | |---|---| | 88–92% | Maintains adequate oxygenation while preserving hypoxic respiratory drive; avoids CO₂ retention | | > 94% | Risks hyperoxemia, suppresses respiratory drive, worsens CO₂ retention (permissive hypoxemia) | ## Supportive Therapy (Concurrent) - Systemic corticosteroids (prednisolone 40–50 mg daily × 5–7 days) - Antibiotics (if signs of infection: purulent sputum, fever) - Bronchodilators (nebulized salbutamol + ipratropium) - Chest physiotherapy [cite:Harrison 21e Ch 254]